✨ Your Portfolio is fetched and updated from zerodha.
Small Pharmaceuticals

Gland Pharma Ltd.

GLAND

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹31,955 Cr.
P/E
41.49

Gland Pharma Ltd.

  • Gland Pharma
  • Caplin Point Lab
  • Gufic Biosciences
  • TJI Pharma - API & CRAMS

FAQs on Gland Pharma Ltd. Shareprice

Gland Pharma has given lower returns compared to its competitors.
Gland Pharma has grown at ~-15.78% over the last 4yrs while peers have grown at a median rate of 14.63%

Gland Pharma is expensive when considering the PE ratio, however latest EV/EBIDTA is < 3 yr avg EV/EBIDTA.
Latest PE of Gland Pharma is 41.77, while 3 year average PE is 40.52.
Also latest EV/EBITDA of Gland Pharma is 21.78 while 3yr average is 25.62.

View FAQ's On Business

Growth Table

  • Gland Pharma Ltd.
  • Caplin Point Lab
  • Gufic Biosciences

Balance Sheet

  • Gland Pharma Ltd.
  • Caplin Point Lab
  • Gufic Biosciences

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Gland Pharma Ltd.
  • Caplin Point Lab
  • Gufic Biosciences

Cash Flow

  • Gland Pharma Ltd.
  • Caplin Point Lab
  • Gufic Biosciences

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Gland Pharma Ltd.
  • Caplin Point Lab
  • Gufic Biosciences

Quarterly Results

  • Gland Pharma Ltd.
  • Caplin Point Lab
  • Gufic Biosciences

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Gland Pharma Ltd. Financials

Balance sheet of Gland Pharma is strong.
It shouldn't have solvency or liquidity issues.

The net debt of Gland Pharma is decreasing.
Latest net debt of Gland Pharma is -₹4,843.19 Crs as of Mar-25.
This is less than Mar-24 when it was -₹3,359.07 Crs.

The profit is oscillating.
The profit of Gland Pharma is ₹770 Crs for TTM, ₹699 Crs for Mar 2025 and ₹772 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Gland Pharma latest dividend payout ratio is 42.46% and 3yr average dividend payout ratio is 42.55%

Companies resources are allocated to majorly productive assets like Plant & Machinery and unproductive assets like Cash & Short Term Investments, Short Term Loans & Advances

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech